BARTELS RUBELLA IGG EIA— 510(k) K922586

Name: FDA 510(k) clearance K922586
Creator: U.S. Food and Drug Administration
Published: 1992-09-17

Substantially Equivalent

Baxter Diagnostics, Inc.

FDA 510(k) clearance K922586 for BARTELS RUBELLA IGG EIA, Substantially Equivalent on 1992-09-17. Applicant: Baxter Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Baxter Diagnostics, Inc.
Product code: Code LFX
Device class: Class 2
Regulation: 21 CFR 866.3510
Advisory panel: Microbiology
Date received: 1992-05-27
Decision date: 1992-09-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LFX

view all

K250588 — Access Rubella IgG2025-11-17
K243168 — Alinity i Rubella IgG2025-06-20
K122397 — LIAISON RUBELLA IGM, LIAISON CONTROL RUBELLA IGM2012-09-06
K093101 — MAGO 4S2011-01-21
K092587 — BIOPLEX 2200 RUBELLA & CMV IGM KIT ON THE BIOPLEX 2200 MULTI ANALYTE DETECTION SYSTEM2010-12-03

More clearances from Baxter Diagnostics, Inc.

view all

K934458 — DRIED GRAM-POSITIVE MIC/COMBO PANELS1995-07-18
K950817 — DRIED GRAM POSITIVE MIC/COMBO PANELS/PNEUMOCOCCI1995-04-25
K935704 — DRIED GRAM-NEGATIVE MIC//COMBO PANELS1995-04-14
K950570 — STRATUS PROGESTERONE FLUOROMETRIC ENZYME IMMUNOASSAY1995-04-11
K945235 — DRIED GRAM-POSITIVE MIC/COMBO PANELS1995-03-07

Data sourced from openFDA. This site is unofficial and independent of the FDA.